[Federal Register Volume 73, Number 152 (Wednesday, August 6, 2008)]
[Notices]
[Pages 45781-45782]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-17965]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated February 12, 2008 and published in the Federal 
Register on February 21, 2008, (73 FR 9591), United States 
Pharmacopeial Convention, 12601 Twinbrook Parkway, Rockville, Maryland 
20852, made application to the Drug Enforcement Administration (DEA) to 
be registered as an importer of the basic classes of controlled 
substances listed in schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Cathinone (1235)............................  I
Methaqualone (2565).........................  I
Lysergic acid diethylamide (7315)...........  I
Marihuana (7360)............................  I
Tetrahydrocannabinols (7370)................  I
4-Methyl-2,5-dimethoxyamphetamine (7395)....  I
3,4-Methylenedioxyamphetamine (7400)........  I
Codeine-n-oxide (9053)......................  I
Heroin (9200)...............................  I
Amphetamine (1100)..........................  II

[[Page 45782]]

 
Methamphetamine (1105)......................  II
Phenmetrazine (1631)........................  II
Methylphenidate (1724)......................  II
Amobarbital (2125)..........................  II
Pentobarbital (2270)........................  II
Secobarbital (2315).........................  II
Glutethimide (2550).........................  II
Phencyclidine (7471)........................  II
Alphaprodine (9010).........................  II
Anileridine (9020)..........................  II
Cocaine (9041)..............................  II
Codeine (9050)..............................  II
Dihydrocodeine (9120).......................  II
Oxycodone (9143)............................  II
Hydromorphone (9150)........................  II
Diphenoxylate (9170)........................  II
Hydrocodone (9193)..........................  II
Levorphanol (9220)..........................  II
Meperidine (9230)...........................  II
Methadone (9250)............................  II
Dextropropoxyphene, bulk (non-dosage forms)   II
 (9273).
Morphine (9300).............................  II
Thebaine (9333).............................  II
Oxymorphone (9652)..........................  II
Noroxymorphone (9668).......................  II
Alfentanil (9737)...........................  II
Sufentanil (9740)...........................  II
Fentanyl (9801).............................  II
------------------------------------------------------------------------

    The company plans to import reference standards for sale to 
researchers and analytical labs.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the 
registration of United States Pharmacopeial Convention to import the 
basic classes of controlled substances is consistent with the public 
interest and with United States obligations under international 
treaties, conventions, or protocols in effect on May 1, 1971, at this 
time. DEA has investigated United States Pharmacopeial Convention to 
ensure that the company's registration is consistent with the public 
interest. The investigation has included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 
958(a), and in accordance with 21 CFR 1301.34, the above named company 
is granted registration as an importer of the basic classes of 
controlled substances listed.

    Dated: July 29, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E8-17965 Filed 8-5-08; 8:45 am]
BILLING CODE 4410-09-P